Table 2.
Development |
Evaluation |
||
Train |
Validation |
||
Images, N | 398 | 99 | 209 |
Patient demographics | |||
Unique individuals, N | 308 | 77 | 191 |
Age, average ± SD | 25.5 ± 10.9 | 27.0 ± 12.6 | 26.4 ± 11.6 |
Female/total patients, % | 63.5 | 66.6 | 68.3 |
Atrophy severity distribution, n (%) | |||
Meiboscore 0 | 73 (18.3) | 18 (18.2) | 38 (18.2) |
Meiboscore 1 | 267 (67.1) | 67 (67.7) | 142 (67.9) |
Meiboscore 2 | 53 (13.3) | 13 (13.1) | 27 (12.9) |
Meiboscore 3 | 5 (1.3) | 1 (1.0) | 2 (1.0) |